MBiotech Alum in the News: Ilia Tikhomirov, Class of 2007

Wednesday, February 6, 2013 - 10:00am

Ilia Tikhomirov, MBiotech Class of 2007

AvidBiologics Inc., a life sciences company developing antibody-drug conjugates (ADCs), partners with the National Research Council Canada (NRC) to develop three novel ADCs for the treatment of cancer. "This partnership transforms AvidBiologics into a leading ADC company with one of the most compelling ADC pipelines in the industry worldwide", said Ilia Tikhomirov, CEO of AvidBiologics.

Ilia Tikhomirov, CEO & President of AvidBiologics, is an alumnus of the MBiotech Program, Class of 2007.

Read the news release here.